Sonrotoclax
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
890.1
Molecular Formula
C49H59N7O7S
Notes
Research use only, not for human use.
Receptor
BCL
CAS Number
2383086-06-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Connexin 45/GJC1 Antibody (5B9.2) [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/genprice3.png)
NBP2-29754JF549 0.1 mL
Mouse Monoclonal Connexin 45/GJC1 Antibody (5B9.2) [Janelia Fluor 549]
Ask
View Details 
MBS6231266-01 0.1 mL
EIF4E2 (EIF4E2, EIF4EL3, Eukaryotic translation initiation factor 4E type 2, Eukaryotic translation initiation factor 4E homologous protein, Eukaryotic translation initiation factor 4E-like 3, eIF4E-like protein 4E-LP, mRNA cap-binding protein 4EHP, mRNA
Ask
View Details MBS6231266-02 5x 0.1 mL
EIF4E2 (EIF4E2, EIF4EL3, Eukaryotic translation initiation factor 4E type 2, Eukaryotic translation initiation factor 4E homologous protein, Eukaryotic translation initiation factor 4E-like 3, eIF4E-like protein 4E-LP, mRNA cap-binding protein 4EHP, mRNA
Ask
View Details